Cisplatin combined with irinotecan or etoposide for untreated extensive‐stage small cell lung cancer: A multicenter randomized controlled clinical trial

Publisher： John Wiley & Sons Inc

E-ISSN： 1759-7714|6|6|785-791

ISSN： 1759-7706

Source： Thoracic Cancer, Vol.6, Iss.6, 2015-11, pp. : 785-791

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Percutaneous radiofrequency ablation for medically inoperable patients with clinical stage I non‐small cell lung cancer

By  

Thoracic Cancer, Vol. 6, Iss. 3, 2015-05 ,pp. : 327-333

John Wiley & Sons Inc

Access to resources Recommend Favorite

Heterogeneous prognosis and adjuvant chemotherapy in pathological stage I non‐small cell lung cancer patients

By  

Thoracic Cancer, Vol. 6, Iss. 5, 2015-09 ,pp. : 620-628

John Wiley & Sons Inc

Access to resources Recommend Favorite

Does the response to induction chemotherapy impact the timing of thoracic radiotherapy for limited‐stage small‐cell lung cancer?

By  

Thoracic Cancer, Vol. 6, Iss. 5, 2015-09 ,pp. : 605-612

John Wiley & Sons Inc

Access to resources Recommend Favorite

Selection of proper candidates with resected pathological stage IIIA‐N2 non‐small cell lung cancer for postoperative radiotherapy

By  

Thoracic Cancer, Vol. 6, Iss. 3, 2015-05 ,pp. : 346-353

John Wiley & Sons Inc

Access to resources Recommend Favorite

Survival analysis of patients with advanced non‐small cell lung cancer receiving tyrosine kinase inhibitor (TKI) treatment: A multi‐center retrospective study

By  

Thoracic Cancer, Vol. 9, Iss. 2, 2018-02 ,pp. : 278-283

John Wiley & Sons Inc

Access to resources Recommend Favorite